Brief: Xspray Pharma Announces Positive Clinical Data For Its Lead Product Candidate HyNap-Dasa

Xspray Pharma publ AB

09/09/2018 20:08

Sept 9 (Reuters) - XSpray Pharma AB (publ)  XSPRAY.ST :
    * XSPRAY PHARMA ANNOUNCES POSITIVE CLINICAL DATA FOR ITS
LEAD
PRODUCT CANDIDATE HYNAP-DASA
    * XSPRAY PHARMA AB (PUBL) - STUDY RESULTS CONFIRMED ITS
PRIMARY
AIM TO SHOW BIOEQUIVALENCE OF AN OPTIMIZED FORMULATION OF
HYNAP-DASA COMPARED TO SPRYCEL

Source text for Eikon:  ID:nWkr88NP60 
Further company coverage:  XSPRAY.ST 

 ((Reuters.Briefs@thomsonreuters.com;))